Approaching pre-Diabetes

Journal of Diabetes and its Complications

Volumn 28, Issue 2, 2014, Pages 226-233

  Perreault, Leigh ^a   Færch, Kristine ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b STENO DIABETES CENTER   (Denmark)

Author keywords

Impaired fasting glucose; Impaired glucose tolerance

Indexed keywords

GLUCAGON; GLUCOSE; HEMOGLOBIN A1C; INCRETIN; INSULIN; METFORMIN;

ARTICLE; CLINICAL TRIAL (TOPIC); GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; SCREENING;

IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE;

DIABETES MELLITUS, TYPE 2; HUMANS; MASS SCREENING; PREDIABETIC STATE; RISK FACTORS;

EID: 84896713532     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2013.10.008     Document Type: Review

References (88)

1. M. Abdul-Ghani, and R.A. DeFronzo Fasting hyperglycemia impairs glucose - but not insulin-mediated suppression of glucagon secretion Journal of Clinical Endocrinology and Metabolism 92 5 2007 1778 1784
2. M.A. Abdul-Ghani, C.P. Jenkinson, D.K. Richardson, D. Tripathy, and R.A. DeFronzo Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: Results from the Veterans Administration Genetic Epidemiology Study Diabetes 55 5 2006 1430 1435
3. M.A. Abdul-Ghani, M. Molina-Carrion, R. Jani, C. Jenkinson, and R.A. Defronzo Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin Acta Diabetologica 45 3 2008 147 150
4. B. Ahren, and H. Larsson Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations Diabetologia 44 11 2001 1998 2003
5. B. Ahren, and G. Pacini Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance American Journal of Physiology 273 4 Pt 1 1997 E701 E707
6. M. Alssema, J.M. Rijkelijkhuizen, J.J. Holst, T. Teerlink, P.G. Scheffer, and E.M. Eekhoff et al. Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT European journal of endocrinology/European Federation of Endocrine Societies 169 4 2013 421 430
7. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group Diabetes 28 12 1979 1039 1057
8. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20 7 1997 1183 1197
9. Diagnosis and classification of diabetes mellitus Diabetes Care 27 Suppl 1 2004 S5 S10
10. Standards of medical care in diabetes - 2010 Diabetes Care 33 Suppl 1 2010 S11 S61
11. Standards of medical care in diabetes - 2013 Diabetes Care 36 Suppl 1 2013 S11 S66
12. G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, and G. Toffolo et al. Pathogenesis of pre-diabetes: Mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance Diabetes 55 12 2006 3536 3549
13. G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, and G. Toffolo et al. Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes Diabetes 56 4 2007 1113 1119
14. T.A. Buchanan, A.H. Xiang, R.K. Peters, S.L. Kjos, A. Marroquin, and J. Goico et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women Diabetes 51 9 2002 2796 2803
15. K.J. Chang-Chen, R. Mullur, and E. Bernal-Mizrachi Beta-cell failure as a complication of diabetes Reviews in Endocrine & Metabolic Disorders 9 4 2008 329 343
16. Y.J. Cheng, E.W. Gregg, L.S. Geiss, G. Imperatore, D.E. Williams, and X. Zhang et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds Diabetes Care 32 11 2009 2027 2032
17. J.L. Chiasson, R.G. Josse, R. Gomis, M. Hanefeld, A. Karasik, and M. Laakso Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial Lancet 359 9323 2002 2072 2077
18. J.L. Chiasson, R.G. Josse, R. Gomis, M. Hanefeld, A. Karasik, and M. Laakso Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: The STOP-NIDDM trial JAMA: the journal of the American Medical Association 290 4 2003 486 494
19. J.O. Christensen, A. Sandbaek, T. Lauritzen, and K. Borch-Johnsen Population-based stepwise screening for unrecognised type 2 diabetes is ineffective in general practice despite reliable algorithms Diabetologia 47 9 2004 1566 1573
20. J.N. Clore, P.S. Glickman, S.T. Helm, J.E. Nestler, and W.G. Blackard Evidence for dual control mechanism regulating hepatic glucose output in nondiabetic men Diabetes 40 8 1991 1033 1040
21. C.C. Cowie, K.F. Rust, E.S. Ford, M.S. Eberhardt, D.D. Byrd-Holt, and C. Li et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006 Diabetes Care 32 2 2009 287 294
22. J. Crandall, D. Schade, Y. Ma, W.Y. Fujimoto, E. Barrett-Connor, and S. Fowler et al. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 61 10 2006 1075 1081
23. E.M. Dalsgaard, J.O. Christensen, M.V. Skriver, K. Borch-Johnsen, T. Lauritzen, and A. Sandbaek Comparison of different stepwise screening strategies for type 2 diabetes: Finding from Danish general practice, Addition-DK Primary Care Diabetes 4 4 2010 223 229
24. F. de Vegt, J.M. Dekker, A. Jager, E. Hienkens, P.J. Kostense, and C.D. Stehouwer et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study JAMA 285 16 2001 2109 2113
25. R.A. Defronzo Banting lecture. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus Diabetes 58 4 2009 773 795
26. R.A. DeFronzo, D. Tripathy, D.C. Schwenke, M. Banerji, G.A. Bray, and T.A. Buchanan et al. Pioglitazone for diabetes prevention in impaired glucose tolerance New England Journal of Medicine 364 12 2011 1104 1115
27. S. Engberg, D. Vistisen, C. Lau, C. Glumer, T. Jorgensen, and O. Pedersen et al. Progression to impaired glucose regulation and diabetes in the population-based Inter99 study Diabetes Care 32 4 2009 606 611
28. K.F. Eriksson, and F. Lindgarde Prevention of type 2 (non-insulin- dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study Diabetologia 34 12 1991 891 898
29. K.W.D. Faerch, A.G. Tabak, L. Perreault, C. Herder, E.J. Brunner, and M. Kivimaki et al. Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: A post-hoc analysis of the longitudinal Whitehall II cohort study Lancet Endocrinology and Diabetes 1 1 2013 43 51
30. K. Faerch, A. Vaag, J.J. Holst, C. Glumer, O. Pedersen, and K. Borch-Johnsen Impaired fasting glycaemia vs impaired glucose tolerance: Similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action Diabetologia 51 5 2008 853 861
31. K. Faerch, A. Vaag, J.J. Holst, T. Hansen, T. Jorgensen, and K. Borch-Johnsen The natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance - the Inter99 study Diabetes Care 32 3 2009 439 444
32. I.D. Federation Diabetes atlas, 5th edition update for 2012 2012
33. A. Festa, R. D'Agostino Jr., A.J. Hanley, A.J. Karter, M.F. Saad, and S.M. Haffner Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose Diabetes 53 6 2004 1549 1555
34. A. Festa, K. Williams, R. D'Agostino Jr., L.E. Wagenknecht, and S.M. Haffner The natural course of beta-cell function in nondiabetic and diabetic individuals: The Insulin Resistance Atherosclerosis Study Diabetes 55 4 2006 1114 1120
35. E.S. Ford, G. Zhao, and C. Li Pre-diabetes and the risk for cardiovascular disease: A systematic review of the evidence Journal of the American College of Cardiology 55 13 2010 1310 1317
36. A. Fritsche, N. Stefan, E. Hardt, H. Haring, and M. Stumvoll Characterisation of beta-cell dysfunction of impaired glucose tolerance: Evidence for impairment of incretin-induced insulin secretion Diabetologia 43 7 2000 852 858
37. A.J. Garber, M.J. Abrahamson, J.I. Barzilay, L. Blonde, Z.T. Bloomgarden, and M.A. Bush et al. AACE comprehensive diabetes management algorithm 2013 Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 19 2 2013 327 336
38. H.C. Gerstein, S. Yusuf, J. Bosch, J. Pogue, P. Sheridan, and N. Dinccag et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomised controlled trial Lancet 368 9541 2006 1096 1105
39. R.B. Goldberg, M. Temprosa, S. Haffner, T.J. Orchard, R.E. Ratner, and S.E. Fowler et al. Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: The Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group Diabetes Care 32 4 2009 726 732
40. K.E. Heikes, D.M. Eddy, B. Arondekar, and L. Schlessinger Diabetes Risk Calculator: A simple tool for detecting undiagnosed diabetes and pre-diabetes Diabetes Care 31 5 2008 1040 1045
41. E. Henkel, M. Menschikowski, C. Koehler, W. Leonhardt, and M. Hanefeld Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus Metabolism 54 9 2005 1168 1173
42. R.R. Holman, S.M. Haffner, J.J. McMurray, M.A. Bethel, B. Holzhauer, and T.A. Hua et al. Effect of nateglinide on the incidence of diabetes and cardiovascular events The New England journal of medicine 362 16 2010 1463 1476
43. R. Jani, M. Molina, M. Matsuda, B. Balas, A. Chavez, and R.A. DeFronzo et al. Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range Diabetes Care 31 2 2008 311 315
44. S.P. Juraschek, M.W. Steffes, and E. Selvin Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose Clinical Chemistry 58 12 2012 1648 1655
45. K. Kantartzis, J. Machann, F. Schick, A. Fritsche, H.U. Haring, and N. Stefan The impact of liver fat vs visceral fat in determining categories of prediabetes Diabetologia 53 5 2010 882 889
46. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, and E.A. Walker et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin New England Journal of Medicine 346 6 2002 393 403
47. W.C. Knowler, S.E. Fowler, R.F. Hamman, C.A. Christophi, H.J. Hoffman, and A.T. Brenneman et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study Lancet 374 9702 2009 1677 1686
48. M. Laakso, J. Zilinskaite, T. Hansen, T.W. Boesgaard, M. Vanttinen, and A. Stancakova et al. Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study Diabetologia 51 3 2008 502 511
49. X. Li, M. Xia, H. Ma, Y. Hu, H. Yan, and W. He et al. Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: A community-based study in Chinese PLoS One 8 7 2013 e65210
50. J.B. Meigs, D.C. Muller, D.M. Nathan, D.R. Blake, and R. Andres The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging Diabetes 52 6 2003 1475 1484
51. C. Meyer, W. Pimenta, H.J. Woerle, T. Van Haeften, E. Szoke, and A. Mitrakou et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans Diabetes Care 29 8 2006 1909 1914
52. A. Mitrakou, D. Kelley, M. Mokan, T. Veneman, T. Pangburn, and J. Reilly et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance New England Journal of Medicine 326 1 1992 22 29
53. J.M. Mooy, P.A. Grootenhuis, H. de Vries, P.J. Kostense, C. Popp-Snijders, and L.M. Bouter et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: The Hoorn Study Diabetologia 39 3 1996 298 305
54. D.H. Morris, K. Khunti, F. Achana, B. Srinivasan, L.J. Gray, and M.J. Davies et al. Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: A meta-analysis Diabetologia 56 7 2013 1489 1493
55. E. Muscelli, A. Mari, A. Casolaro, S. Camastra, G. Seghieri, and A. Gastaldelli et al. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients Diabetes 57 5 2008 1340 1348
56. D.M. Nathan, M.B. Davidson, R.A. DeFronzo, R.J. Heine, R.R. Henry, and R. Pratley et al. Impaired fasting glucose and impaired glucose tolerance: Implications for care Diabetes Care 30 3 2007 753 759
57. M.A. Nauck, I. Vardarli, C.F. Deacon, J.J. Holst, and J.J. Meier Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: What is up, what is down? Diabetologia 54 1 2011 10 18
58. T.J. Orchard, M. Temprosa, E. Barrett-Connor, S.E. Fowler, R.B. Goldberg, and K.J. Mather et al. Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: A report from the DPP Outcomes Study Diabetic Medicine 30 1 2013 46 55
59. W.H. Organization Use of the glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: Abbreviated report of a WHO Consultation 2011 Switzerland Geneva
60. X.R. Pan, G.W. Li, Y.H. Hu, J.X. Wang, W.Y. Yang, and Z.X. An et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study Diabetes Care 20 4 1997 537 544
61. L. Perreault, B.C. Bergman, D.M. Hunerdosse, M.C. Playdon, and R.H. Eckel Inflexibility in intramuscular triglyceride fractional synthesis distinguishes prediabetes from obesity in humans Obesity 18 8 2010 1524 1531
62. L. Perreault, B.C. Bergman, M.C. Playdon, C. Dalla Man, C. Cobelli, and R.H. Eckel Impaired fasting glucose with or without impaired glucose tolerance: Progressive or parallel states of prediabetes? American journal of physiology Endocrinology and metabolism 295 2 2008 E428 E435
63. L. Perreault, S.E. Kahn, C.A. Christophi, W.C. Knowler, and R.F. Hamman Regression from pre-diabetes to normal glucose regulation in the Diabetes Prevention Program Diabetes Care 32 9 2009 1583 1588
64. L. Perreault, Y. Ma, S. Dagogo-Jack, E. Horton, D. Marrero, and J. Crandall et al. Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program Diabetes Care 31 7 2008 1416 1421
65. L. Perreault, Q. Pan, K.J. Mather, K.E. Watson, R.F. Hamman, and S.E. Kahn Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: Results from the Diabetes Prevention Program Outcomes Study Lancet 379 9833 2012 2243 2251
66. L.S. Phillips, and D.E. Olson Diabetes: Normal glucose levels should be the goal Nature Reviews Endocrinology 8 9 2012 510 512
67. Q. Qiao, J. Lindstrom, T.T. Valle, and J. Tuomilehto Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia Diabetic Medicine 20 12 2003 1027 1033
68. Q. Qiao, K. Pyorala, M. Pyorala, A. Nissinen, J. Lindstrom, and R. Tilvis et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose European Heart Journal 23 16 2002 1267 1275
69. A. Ramachandran, C. Snehalatha, S. Mary, B. Mukesh, A.D. Bhaskar, and V. Vijay The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) Diabetologia 49 2 2006 289 297
70. S.S. Rasmussen, C. Glumer, A. Sandbaek, T. Lauritzen, and K. Borch-Johnsen Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: The ADDITION Study Denmark Diabetologia 50 2 2007 293 297
71. L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, and M.J. de Boer et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) European Heart Journal 28 1 2007 88 136
72. T. Saito, M. Watanabe, J. Nishida, T. Izumi, M. Omura, and T. Takagi et al. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: A randomized controlled trial Archives of Internal Medicine 171 15 2011 1352 1360
73. S.H. Saydah, C.M. Loria, M.S. Eberhardt, and F.L. Brancati Subclinical states of glucose intolerance and risk of death in the U.S Diabetes Care 24 3 2001 447 453
74. S. Soderberg, P. Zimmet, J. Tuomilehto, M. de Courten, G.K. Dowse, and P. Chitson et al. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius Journal of Internal Medicine 256 1 2004 37 47
75. A.G. Tabak, M. Jokela, T.N. Akbaraly, E.J. Brunner, M. Kivimaki, and D.R. Witte Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: An analysis from the Whitehall II study Lancet 373 9682 2009 2215 2221
76. R.J. Tapp, J.E. Shaw, P.Z. Zimmet, B. Balkau, S.J. Chadban, and A.M. Tonkin et al. Albuminuria is evident in the early stages of diabetes onset: Results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) American Journal of Kidney Diseases 44 5 2004 792 798
77. The Diabetes Prevention Program The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program Diabetic Medicine 24 2 2007 137 144
78. A. Tirosh, I. Shai, D. Tekes-Manova, E. Israeli, D. Pereg, and T. Shochat et al. Normal fasting plasma glucose levels and type 2 diabetes in young men New England Journal of Medicine 353 14 2005 1454 1462
79. M.B. Toft-Nielsen, M.B. Damholt, S. Madsbad, L.M. Hilsted, T.E. Hughes, and B.K. Michelsen et al. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients The Journal of clinical endocrinology and metabolism 86 8 2001 3717 3723
80. J.S. Torgerson, J. Hauptman, M.N. Boldrin, and L. Sjostrom XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients Diabetes Care 27 1 2004 155 161
81. D. Tripathy, P. Almgren, T. Tuomi, and L. Groop Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity Diabetes Care 27 9 2004 2204 2210
82. J. Tuomilehto, J. Lindstrom, J.G. Eriksson, T.T. Valle, H. Hamalainen, and P. Ilanne-Parikka et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance New England Journal of Medicine 344 18 2001 1343 1350
83. N.J. van der Zijl, G.H. Goossens, C.C. Moors, D.H. van Raalte, M.H. Muskiet, and P.J. Pouwels et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: Impact on beta-cell function in individuals with impaired glucose metabolism The Journal of clinical endocrinology and metabolism 96 2 2011 459 467
84. K. Vollmer, J.J. Holst, B. Baller, M. Ellrichmann, M.A. Nauck, and W.E. Schmidt et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance Diabetes 57 3 2008 678 687
85. C. Weyer, C. Bogardus, and R.E. Pratley Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance Diabetes 48 11 1999 2197 2203
86. X. Zhang, E.W. Gregg, D.F. Williamson, L.E. Barker, W. Thomas, and K.M. Bullard et al. A1C level and future risk of diabetes: A systematic review Diabetes Care 33 7 2010 1665 1673
87. D. Ziegler, W. Rathmann, T. Dickhaus, C. Meisinger, and A. Mielck Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: The MONICA/KORA Augsburg Surveys S2 and S3 Diabetes Care 31 3 2008 464 469
88. B. Zinman, S.B. Harris, J. Neuman, H.C. Gerstein, R.R. Retnakaran, and J. Raboud et al. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): A double-blind randomised controlled study Lancet 376 9735 2010 103 111